PSMA Expression in the Neovasculature Associated With Rectal Adenocarcinoma: A Potential Stromal Target for Nuclear Theranostics

Clin Nucl Med. 2020 Jul;45(7):e309-e310. doi: 10.1097/RLU.0000000000003066.

Abstract

We report the case of a 63-year-old man who underwent MRI and Ga-PSMA-11 PET/CT for biochemical recurrence localization after radical prostatectomy (serum PSA, 0.25 ng/mL) and describe the incidental discovery of a rectal adenocarcinoma. Immunohistochemical analysis showed PSMA staining in the tumor-associated neovasculature, but not in normal vasculature, or tumor cells. After surgical removal, he was treated with salvage radiotherapy to the postoperative prostate bed. This case example has several implications: the findings confirm the expression of PSMA in the tumor-associated neovasculature of a rectal cancer, nonprostate cancers' stroma may represent a potentially relevant target for nuclear theranostics.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / blood supply
  • Adenocarcinoma / diagnostic imaging
  • Adenocarcinoma / metabolism*
  • Adenocarcinoma / therapy
  • Antigens, Surface / metabolism*
  • Gene Expression Regulation, Neoplastic*
  • Glutamate Carboxypeptidase II / metabolism*
  • Humans
  • Incidental Findings
  • Male
  • Middle Aged
  • Molecular Targeted Therapy
  • Neovascularization, Pathologic / metabolism*
  • Nuclear Medicine*
  • Positron Emission Tomography Computed Tomography
  • Prostatectomy
  • Rectal Neoplasms / blood supply
  • Rectal Neoplasms / diagnostic imaging
  • Rectal Neoplasms / metabolism*
  • Rectal Neoplasms / therapy
  • Theranostic Nanomedicine*

Substances

  • Antigens, Surface
  • FOLH1 protein, human
  • Glutamate Carboxypeptidase II